Company
ChinaHarry Harinder Singh Gill, M.D., Hong Kong, China – FDA Inspections
Inspection records and compliance data for Harry Harinder Singh Gill, M.D. in Hong Kong. 1 FDA inspection on record, last inspected May 08, 2026.
Company Profile
This profile covers Harry Harinder Singh Gill, M.D. based in Hong Kong, China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected May 8, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 8, 2026 | Not classified | Human Drugs | 1320044 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Beijing Wanhui Double-Crane Pharmaceutical Co Ltd
Henan Yuchen Pharmaceutical Co., Ltd.
Chongqing Benji Biotechnology Co., Ltd.
Haiyan Tu, MD, MM
Yiran Huang
Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd.
Lab Douce Cosmetics (Shenzhen) Co., Ltd.
Henan Lingrui Pharmaceutical Co.,Ltd.
Nantong Strip Medical Supply Co Ltd
Shanxi Xinbaoyuan Pharmaceutical Co., Ltd.
Company Information
Name
Harry Harinder Singh Gill, M.D.
FEI Number
3042920273
Address
Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, 4/F, Professor Block, Hong Kong, China
Country
China
ID: 5ae051db-e7e5-4b13-b4a4-4d245608d56e